Argonaut has near-term availability on our fill/finish line for COVID-19 vaccines and therapeutics. Projects can begin filling for pre-clinical through phase III trials as early as May, cutting months from the typical timeline.
Every additional vial produced means another patient protected against COVID-19. Argonaut’s state-of-the-art Bausch + Ströbel line is optimized to protect your valuable drug against loss and risk during filling.
Get your critical kit to market faster. Our team has extensive experience with PCR, NGS, and Antibody-based assay manufacturing. Formulation, filling, kitting, lyophilization, QC, and fulfillment all available under one roof.
Argonaut’s mission is to help your team succeed. Experienced project managers and manufacturing staff keep your projects on track. Our facility will continue to operate during the COVID-19 outbreak, supplying clients worldwide with life-saving technologies.